IQ EQ FUND MANAGEMENT IRELAND Ltd reduced its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 28.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 26,441 shares of the industrial products company's stock after selling 10,696 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd's holdings in Xylem were worth $3,068,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Lee Danner & Bass Inc. purchased a new stake in Xylem during the fourth quarter worth $30,000. Rialto Wealth Management LLC acquired a new position in shares of Xylem in the fourth quarter worth about $31,000. Heck Capital Advisors LLC purchased a new stake in shares of Xylem during the 4th quarter worth about $36,000. Pathway Financial Advisers LLC grew its position in shares of Xylem by 122.4% during the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock valued at $37,000 after acquiring an additional 175 shares during the period. Finally, SRS Capital Advisors Inc. increased its stake in shares of Xylem by 69.5% in the 4th quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock valued at $37,000 after purchasing an additional 130 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
Xylem Trading Down 0.9 %
XYL traded down $1.04 on Monday, hitting $118.40. The company had a trading volume of 419,627 shares, compared to its average volume of 1,308,721. The company's fifty day moving average price is $125.70 and its 200 day moving average price is $125.85. Xylem Inc. has a 1 year low of $113.26 and a 1 year high of $146.08. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The firm has a market cap of $28.78 billion, a P/E ratio of 32.37, a PEG ratio of 2.33 and a beta of 1.08.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.12 by $0.06. The business had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The business's revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.99 EPS. As a group, equities analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Stockholders of record on Tuesday, February 18th were given a dividend of $0.40 per share. This is a positive change from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a dividend yield of 1.35%. The ex-dividend date was Tuesday, February 18th. Xylem's dividend payout ratio (DPR) is currently 43.72%.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on XYL. Stifel Nicolaus decreased their price target on shares of Xylem from $166.00 to $150.00 and set a "buy" rating on the stock in a research note on Friday, January 24th. Wolfe Research reiterated a "peer perform" rating on shares of Xylem in a research report on Thursday, December 12th. Citigroup downgraded Xylem from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 5th. Finally, Robert W. Baird upped their target price on shares of Xylem from $139.00 to $148.00 and gave the stock an "outperform" rating in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, Xylem currently has a consensus rating of "Moderate Buy" and a consensus price target of $149.89.
Read Our Latest Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
